14 | 01 | 19Nanoform set to boost world-class nanonization services with appointment of Chief Technology Officer Nanoform, an innovative drug enabling nanotechnology company, has appointed Dr Niklas Sandler as Chief Technology Officer.
07 | 01 | 19Nanoform significantly strengthens commercial organisation with Chief of Business Operations appointment Nanoform, an innovative drug enabling nanotechnology company, has appointed Dr Gonçalo Rebelo de Andrade as Chief of Business Operations.
10 | 12 | 18Nanoform continues rapid expansion with construction of GMP manufacturing plant Nanoform, an innovative drug enabling nanotechnology company, has announced the construction of a GMP manufacturing plant to provide API ‘solution to particle’ nanonization for clinical trials.
29 | 10 | 18Nanoform set to globalize its technology with appointment of a Chief Commercial Officer Nanoform, a Helsinki, Finland-based drug particle engineering and nanotechnology company, is set to globalize its novel nanonization technology with the appointment of Christian Jones as Chief Commercial Officer.
19 | 09 | 18Nanoform set to transform drug development through €7 million investment in patented nanoparticle technology Nanoform, an innovative drug particle engineering and nanotechnology company that provides novel API particle-size reduction services, is continuing its strategic growth through a significant €7 million investment, with Vator Securities acting as the sole bookrunner.